EUVIMEDObjevte EUVIMED
ÜbersichtsarbeitSystematische Übersicht

Marine‐Derived Molecular Glue Degraders: A New Frontier in Targeted Protein Degradation for Treatment of Multi‐Factorial Diseases

Vajagathali Mohammed, B Haridevamuthu, Kathiravan Muthu Kumaradoss, S Karthick Raja Namasivayam iD, Jesu Arockiaraj

Biotechnology and Applied Biochemistry · 2026-04 · 73 (2) · 871-895

DOI: 10.1002/bab.70055 ↗

At a glance

Übersichtsarbeit in Biotechnology and Applied Biochemistry, published online on 2025-10-11. Written by Vajagathali Mohammed and 4 co-authors. Institution: Toxicology and Pharmacology Laboratory, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Katt…. Major MEDLINE topics: Aquatic Organisms, Proteolysis, Neoplasms. Cited 18 times so far (Crossref); 201 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Targeted protein degradation has emerged as a revolutionary approach to the selective elimination of disease‐causing proteins that provides new strategies in the treatment of a variety of conditions. Currently, two major techniques in this area are known as proteolysis targeting chimeras (PROTACs) and molecular glue degraders (MGDs). MGDs can be natural or of synthetic origin, and only limited studies were performed with marine‐derived MGDs. The study is a representation of the systematic review of literature in databases like Scopus, Web of Science, and PubMed about the MGDs from marine sources and deals with an outline of their therapeutic applications. MGDs derived from the ocean have shown great promise in infectious diseases, autoimmune disorders, cancer, and neurotoxicity‐related disorders. Among them are Manumycin A against breast cancer and Khalalide F for treating neurotoxicity. Their identification and characterization are enormous challenges that, notwithstanding the therapeutic promise of MGDs, require advanced technologies and very specialized skills. Their development process is also complex legally and ethically given the imperative to access and use marine genetic resources within the parameters of the Nagoya Protocol on Access and Benefit Sharing. By setting a limit to the exploitation of genetic materials, in this case, marine genetic resources, further research developments in this particular area have especially become difficult due to the Nagoya Protocol. Marine‐derived MGDs are opening a new frontier in drug discovery for the treatment of multi‐factorial diseases with minimal/no side effects. Having the potential to revolutionize future treatment strategies, overcoming technical, legal, and ethical challenges will be important to realizing their full potential and assuring equitable access to such ground‐breaking resources.

Subjects

MeSH terms (MEDLINE)

Aquatic OrganismsProteolysisNeoplasmsHumansAnimals

Author keywords

anticancer | molecule glue degraders | neurotoxicity | proteolysis targeting ch…

Authors and institutions

  • Toxicology and Pharmacology Laboratory, Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu, India.
  • Department of Pharmaceutical Chemistry, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, Tamil Nadu, India.
  • Centre For Applied Research, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, India.

ORCID profiles: S Karthick Raja Namasivayam

Cite

APA

Mohammed, V., Haridevamuthu, B., Kumaradoss, K. M., Namasivayam, S. K. R., & Arockiaraj, J. (2026). Marine‐Derived Molecular Glue Degraders: A New Frontier in Targeted Protein Degradation for Treatment of Multi‐Factorial Diseases. Biotechnology and Applied Biochemistry, 73(2), 871-895. https://doi.org/10.1002/bab.70055

Vancouver

Mohammed V, Haridevamuthu B, Kumaradoss KM, Namasivayam SKR, Arockiaraj J. Marine‐Derived Molecular Glue Degraders: A New Frontier in Targeted Protein Degradation for Treatment of Multi‐Factorial Diseases. Biotechnology and Applied Biochemistry. 2026;73(2):871-895. doi:10.1002/bab.70055

BibTeX
@article{Mohammed2026,
  author = {Mohammed, Vajagathali and Haridevamuthu, B and Kumaradoss, Kathiravan Muthu and Namasivayam, S Karthick Raja and Arockiaraj, Jesu},
  title = {Marine‐Derived Molecular Glue Degraders: A New Frontier in Targeted Protein Degradation for Treatment of Multi‐Factorial Diseases},
  journal = {Biotechnology and Applied Biochemistry},
  year = {2026},
  volume = {73},
  number = {2},
  pages = {871--895},
  doi = {10.1002/bab.70055}
}
Start for free →